This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Past, Present, and Future

Lloyd Paul Aiello, MD, PhD

Arch Ophthalmol. 1996;114(10):1252-1254.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

VASCULARIZATION WITHIN the eye is a fundamental process involved not only in normal ocular development but also in a wide range of ophthalmic diseases. Such seemingly disparate clinical entities as diabetic retinopathy, central retinal vein occlusion, retinopathy of prematurity (ROP), age-related macular degeneration, sickle cell retinopathy, radiation retinopathy, and Eales disease may all eventually lead to uncontrolled vascularization. The potential role of growth factors as mediators of developmental and pathologic intraocular vascularization has been recognized for almost half a century, since the release of an angiogenic factor by the retina was first proposed by Michaelson¹ in 1948.² Subsequently, an extensive search for molecules with the diverse attributes required to account for the clinical observations associated with all of these conditions has been conducted.³ Fibroblast growth factors, insulinlike growth factors, and growth hormone have been evaluated, and, although each has demonstrated interesting associations with clinical disease and potential . . . [Full Text PDF of this Article]

Author Affiliations
Boston, Mass

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?